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Atrophy is regarded a sensitive marker of neurodegenerative pathology. In addition to confirming the well-
known presence of decreased global grey matter and hippocampal volumes in Alzheimer’s disease, this study
investigated whether deep grey matter structure also suffer degeneration in Alzheimer’s disease, and whether
such degeneration is associated with cognitive deterioration. In this cross-sectional correlation study, two
groups were compared on volumes of seven subcortical regions: 70 memory complainers (MCs) and 69 subjects
diagnosed with probable Alzheimer’s disease.Using 3T 3DT1MR images, volumes of nucleus accumbens, amyg-
dala, caudate nucleus, hippocampus, pallidum, putamen and thalamus were automatically calculated by the
FMRIB’s Integrated Registration and Segmentation Tool (FIRST)çalgorithm FMRIB’s Software Library (FSL).
Subsequently, the volumes of the different regions were correlated with cognitive test results. In addition to
finding the expected association between hippocampal atrophy and cognitive decline in Alzheimer’s disease,
volumes of putamen and thalamus were significantly reduced in patients diagnosed with probable Alzheimer’s
disease.We also found that the decrease in volume correlated linearly with impaired global cognitive perfor-
mance. These findings strongly suggest that, beside neo-cortical atrophy, deep grey matter structures in
Alzheimer’s disease suffer atrophy as well and that degenerative processes in the putamen and thalamus,
like the hippocampus, may contribute to cognitive decline in Alzheimer’s disease.
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Abbreviations: CAMCOG-R=Cambridge Cognitive Examination-Revised; FSL=FMRIB’s Software Library;
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Introduction
Characteristic degenerative pathology in Alzheimer’s disease
consists of atrophy and the increased presence of neurofi-
brillary tangles and amyloid plaques. This degenerative
pathology gradually accumulates over a period of years,
long before clinical symptoms become manifest (Jack,
Jr et al., 1999; Smith et al., 2007). Herein, atrophy is
considered a better marker for impaired functioning of
brain regions than the deposits of insoluble proteins in
plaques and tangles, since only a small portion of neurons
contains tangles and the number of neurons that die,
exceeds by far the number that contains tangles (Smith,
2002). Description of cerebral atrophy patterns in the
process of Alzheimer’s disease is considered important,
because it may provide information on the pathogenesis of
Alzheimer’s disease and on the contribution of various
brain structures to cognitive decline.
Structural imaging studies have already identified several
diagnostic markers of Alzheimer’s disease related to
atrophy: hippocampal atrophy (de Leon et al., 1995),
amygdalar atrophy (Horinek et al., 2007), medial temporal
lobe atrophy (Scheltens et al., 1992; de Leon et al., 1993),
precuneus atrophy (Karas et al., 2007), and global grey
matter atrophy (Karas et al., 2004). Most studies have
focused on the neocortex, and especially the hippocampus,
regarding their crucial roles in higher cognitive functions
and memory processes respectively, whereas the basal nuclei
and thalamus have received less attention. There are,
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grey matter structures, besides the hippocampus and the
amygdala, may also occur in the process of Alzheimer’s
disease and may contribute to cognitive deterioration.
In 1990, Braak et al. noted the presence of amyloid
depositions in the striatum (Braak and Braak, 1990). Klunk
et al. added that amyloid depositions are even present in
the striatum in very early stages of the disease in PS1
mutation carriers (Klunk et al., 2007). Both studies
indicated that the striatum is prone to Alzheimer’s disease
pathology. Regarding subcortical atrophy and Alzheimer’s
disease, Ferrarini et al. reported the changes in shape of the
ventricle system in areas adjacent to the amygdala,
thalamus, and caudate nucleus in patients with
Alzheimer’s disease, indicating atrophic changes in those
regions (Ferrarini et al., 2006). Direct measurement of the
caudate nucleus in Alzheimer’s disease patients revealed
diminished volumes of this structure, although propor-
tionate to whole brain atrophy (Almeida et al., 2003).
Direct measurement of subcortical structures in Parkinson’s
disease, another neurodegenerative disorder accompanied in
advanced stages by dementia, also showed decreased
volumes of putamen and pallidum (Geng et al., 2006).
The impaired functioning of the basal nuclei has previously
been related to cognitive dysfunction, since neurodegen-
erative extrapyramidal syndromes commonly show symp-
toms of cognitive dysfunction such as visuospatial deficits,
depression, anxiety and, in progressed stages, clinical
dementia syndrome (Borroni et al., 2007). Atrophy of the
thalamus has also been associated with cognitive decline in
neurodegenerative disorders other than Alzheimer’s disease
such as multiple sclerosis, Huntington’s disease and Lewy-
Body dementia (Barber et al., 2002; Kassubek et al., 2005;
Houtchens et al., 2007). Although little is known about the
specific role that subcortical and thalamic structures have in
cognitive processes, it is well recognized that the thalamus
is essential for generating attention (Newman, 1995) and
it’s anterior and medial nuclei are involved in declarative
memory functioning (Van der Werf et al., 2000). In spite of
all these data, direct measurement of volumes of all large
subcortical structures in Alzheimer’s disease patients,
compared to those without cognitive impairment has not
been assessed before; similarly, the correlation between the
decreasing of their volume and cognitive functioning
has never been reported in the literature.
In this study we used FMRIB’s Integrated Registration and
Segmentation Tool (FIRST) (Patenaude, 2007) to automat-
ically measure the volumes of amygdala, hippocampus,
nucleus accumbens, caudate nucleus, putamen, pallidum
and thalamus in subjects that entered the out-patient
memory clinic of our hospital. The aim of this study is to
assess whether differences exist between volumes of the
basal nuclei and the thalamus of subjects with Alzheimer’s
disease compared to elderly subjects without cognitive
impairment. We hypothesize that smaller volumes of
the basal nuclei and thalamus exist in Alzheimer’s disease
patients due to more severe atrophic changes in those
regions, compared with the volume loss accompanying
‘normal ageing’ in elderly subjects by whom no cognitive
impairment can be objectified. We also hypothesized that
smaller volumes of the deep grey matter structures, when
corrected for age, gender, years of education, intra cranial
volume (ICV) and neocortical grey matter volume, correlate
with poorer cognitive test results.
Methods
Study design
Two hundred and nineteen consecutive patients, who visited the
out-patient’s clinic for memory deficits of the geriatric department
of the Leiden University Medical Center (LUMC) between January
1, 2006 and October 1, 2007 were recruited for this study. All
subjects who visited the clinic complained of memory loss
and were examined according to a standardized protocol, which
included a whole brain MRI, a neuropsychological screening,
and a general medical and neurological examination, by a
neurologist or geriatrist. Cognitive testing took place prior or
after MRI testing with a maximal interval of 14 days. The eventual
diagnose was determined in a multidisciplinary consensus meeting
which employed the National Institute of Neurological and
Communicative Disorders and Stroke and Alzheimer’s Disease and
Related Disorders Association (NINCDS-ADRDA) criteria for
diagnosing probable Alzheimer’s disease (McKhann et al., 1984).
This cross-sectional case-control study was approved by the local
medical-ethical committees. Written informed consent was
obtained from all subjects or from a close relative if a patient
was demented.
Subjects
Subjects came to the memory clinic for a variety of indications,
mostly memory complaints experienced by the patient or notified
by people in his or her environment.
In the multidisciplinary meeting, patients were categorized as
having possible or probable Alzheimer’s disease, mild cognitive
impairment, or a neurological or psychiatric disorder. The
remaining patients, by whom objectively no memory deficits
could be detected, were classified as MCs. Attention was given to
factors that might contribute to memory complaints in this
heterogeneous group. Part of the MCs suffered mild depressions
Geriatric Depression Scale (GDS) 510 (n=12), while in another
part memory was declined due to psycho-social factors such as the
loss of a family member or problems at work (n=17). For over
half of the MCs no clear explanation for subjectively experienced
memory decline was found. Part of them might have a very early
stage of dementia, undetectable by our present means. For our
study we included 139 subjects, of whom complete datasets were
available. Seventy of them were MCs and 69 were probable
Alzheimer’s disease patients.
In total 80 subjects were excluded. Among them were subjects
who did have cognitive impairment detected during neuropsy-
chological testing but did not meet the criteria for probable
Alzheimer’s disease (n=33), or were diagnosed with other forms
of dementia (Frontal Temporal Dementia n=3, Lewy Body
Dementia n=1, Vascular Dementia n=3, Parkinson’s dementia
n=2). Other exclusion criteria for this study included; other
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lus, intracranial tumors, stroke etc.; severe mood-disorders
with GDS510 (n=10); alcohol abuse (n=8); insufficient
scan quality (n=2); and re-examination of the subject neuropsy-
chologically (n=4).
Neuropsychological assessment
The cognitive functioning of all subjects was assessed using
a standardized neuropsychological test battery, including
the Cambridge Cognitive Examination-Revised (CAMCOG-R)
(Roth et al., 1999) incorporating the Mini Mental State
Examination (MMSE) (Folstein et al., 1975). Furthermore all
subjects were examined for signs of depression using the GDS
(Skeith and Yesavage, 1986) to rule out a severe depression as
contributory factor to memory loss or cognitive decline.
MR data acquisition
MRI was performed using a 3.0T whole body MRI scanner
(Philips Medical Systems, Best, The Netherlands). Volume
measurements of the basal nuclei and the thalamus were
performed on 3D-T1-weighted MR images (acquisition parameters
were as follows: TR=9.8ms; TE=4.6ms; flip angle=8; section
thickness=1.2mm; number of sections=120; no section gap;
whole brain coverage; FOV=224mm; matrix=192, reconstruction
matrix=256). Routine T2-weighted MRI and FLAIR were
performed to rule out a mass lesion as contributory factor to
memory loss or cognitive decline.
Measurement of volumes of deep grey matter
structures
The algorithm FIRST, was applied to separately estimate left and
right volumes of seven subcortical regions; amygdala, hippocam-
pus, nucleus accumbens, caudate nucleus, putamen, pallidum and
thalamus. FIRST is part of FMRIB’s Software Library (FSL) and
performs both registration and segmentation of the mentioned
subcortical regions (Patenaude, 2007; Patenaude et al., 2007).
During registration, the input data (3D T1 images) are
transformed to the MNI (Montreal Neurological Institute)
152 standard space, by means of affine transformations based on
12 degrees of freedom (i.e. three translations, three rotations,
three scalings and three skews). After subcortical registration, a
sub-cortical mask is applied, to locate the different subcortical
structures, followed by segmentation based on shape models and
voxel intensities. Absolute volumes of subcortical structures are
calculated, taking into account the transformations made in the
first stage (Patenaude, 2007). Finally a boundary correction is used
to determine which boundary voxels belong to the structure or
not. In this study a Z-value of 3 was used, corresponding to a
99.998% certainty that the voxel belonged to the subcortical
structure. After registration and segmentation of all 139 MR scans,
all segmentated subcortical regions were visually checked for
errors in registration and segmentation. None were found.
Examples of subcortical segmentation, after boundary correction,
of a subject classified as MC and of a subject diagnosed
with probable Alzheimer’s disease, are presented in respectively
Figs 1 and 2.
Brain tissue volume was estimated with SIENAX (Smith et al.,
2002), part of FSL (Smith et al., 2004). SIENAX starts by
extracting brain and skull images from the single whole-head
input data (Smith et al., 2002). Next, tissue-type segmentation
with partial volume estimation is carried out (Zhang et al., 2001)
in order to calculate total volume of brain tissue (including
separate estimates of volumes of grey matter, white matter). For
this study we used the absolute volumes generated by the
algorithm. To obtain neocortical grey matter volume (NeoCor
GM) independent from the deep grey matter structures of interest,
we subtracted the volumes of the hippocampus and amygdala
from the peripheral grey matter volume as given by SIENAX. ICV
was calculated by adding the volumes of cerebral spinal fluid, total
grey matter and total white matter together.
Statistical analysis
SPSS v 14.0 for Windows was used for data analysis. The MCs were
compared for age, educational level (in years of education including
primary school), and ICV with subjects diagnosed with probable
Alzheimer’s disease by one-way independent ANOVA, and com-
pared for gender by a chi-quadrate test. The performed analysis was
2-fold. The first part was designed to assess whether the means of
cortical and deep grey matter volumes (FIRST and SIENAX-output)
in probable Alzheimer’s disease-subjects were decreased compared
with subjects without cognitive impairment. A general linear model
was used in which the volumes of deep grey matter structures were
included as dependent factors and diagnosis as independent. In this
model age and ICV were included as co-variates, and gender as fixed
factor. The Beta differences between the estimated means, adjusted
for age, ICV and gender, for the two groups were calculated, as their
correspondingP-values.AP-value40.05wasconsideredsignificant.
Furthermore, Pearson correlation coefficients were calculated
Fig. 1 FIRST-segmentation: MC.
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matter structures, total brain volume and total white matter volume.
In the second part, correlations between neuropsychological test
results (CAMCOG-R score, executive subtest of CAMCOG-R and
MMSE score) and deep grey matter volumes were assessed on
linearity for MCs and subjects with probable Alzheimer’s disease
separately. For each deep grey matter structure a linear regression
model was designed, in which the different cognitive test scores
were included as the dependent variables and the volume of the
deep grey matter structure as independent variable. Age, gender,
years of education and neo cortical grey matter volume were also
added as independent variables in these models, because of their
expected influence on cognitive test scores. ICV was added as
independent variable to adjust for differences in deep grey matter
volume due to differences in head size between patients. A
collinearity test was performed to rule out multicollinearity
between the independent variables, in which a R
2 above 64%
was considered being a strong correlation.
Results
Group demographic features are presented in Table 1.
MCs differed significantly from probable Alzheimer’s
disease subjects in age (F=38.1, P50.001) in years of
education (F=9.97, P=0.002), and in ICV (one-way
ANOVA; F=5.06, P=0.026), but not in gender
(
2=2.68, P=0.101). The significance of difference
between ICV disappeared if male and female were
compared for separately. Although the male–female ratio
was not significantly different between the MCs and
probable Alzheimer’s disease patients, it was incorporated
as independent factor in the statistical analyses because of
the relatively large number of female probable Alzheimer’s
disease subjects and the known existence of different brain
tissue volumes between the sexes. Age, educational level and
ICV were taken in as co-variates in the following analyses.
Decreased volumes of putamen and
thalamus in Alzheimer’s disease subjects
The mean volumes for all substructures in cubic centi-
metres, computed from the calculated volumes by the
FIRST-algorithm, are shown in Table 2 separately for MCs
and probable Alzheimer’s disease patients. A distinction is
made for male and female mean volumes. Also total brain
volume, white matter and neocortical grey matter are
shown. All structures, except the right amygdala in females,
the left and right caudate nucleus and total white matter in
males, show a decrease in size in absolute volume if MCs
are compared to probable Alzheimer’s disease patients.
When age, gender and ICV differences between subjects
are corrected for, the left and right hippocampus, putamen
and thalamus of probable Alzheimer’s disease subjects are
Fig. 2 FIRST-segmentation: probable Alzheimer’s disease.
Table 1 Demographics and group characteristics
Memory complainers Probable Alzheimer’s disease
MFT o t a l M F T o t a l
N3 5 3 5 7 0 2 5 4 4 6 9
Age inY Mean (SD) 65 (13) 67 (12) 66 (13) 76 (5.8) 77 (8.2) 77 (7 .4)
Edu inY Mean (SD) 12 (3.9) 12 (3.5) 12 (3.7) 11. (4.5) 8.9 (3.5) 9.8 (4.0)
ICV in cm
3 Mean (SD) 1565 (87 .5) 1390 (1 18) 1477 (135) 1541 (121) 1361 (92.4) 1426 (135)
CAMCOG-R Mean (SD) 90 (7 .0) 90 (7 .3) 90 (7 .1) 69 (15) 61 (14) 64 (15)
CAMCOG-R exe Mean (SD) 15 (2.6) 15 (3.1) 15 (2.9) 9.6 (3.6) 9.2 (3.5) 9.4 (3.5)
MMSE Mean (SD) 28 (1.6) 27 (2.7) 27 (2.3) 20 (5.0) 17 (4.4) 18 (4.7)
The groups MC and probable Alzheimer’s disease significantly differ in age (one-way ANOVA: F=38. 1 ,P50.001) years of education
(one-way ANOVA; F=9 . 97 ,P=0.002), and ICV (one-way ANOVA; F=5 . 06,P=0 . 026)butnotingender( X
2-value=2.68, P= 0.101).
AgeinY=ageinyears;Ed uinY=ed ucat ionalle velinyearsincl ud ingpri maryschool ;ICV=Int raC ran ialV ol ume;
CAMCOG-R exe=CAMbridge COGnition examination Revised.executive functioning; M=male; F=female.
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Table 2). Also total brain volume and neocortical grey
matter volume are significantly reduced in probable
Alzheimer’s disease subjects. Table 2 also shows the
Pearson correlation coefficients between neo-cortical grey
matter volume and the volumes of the deep grey matter
structures, and their corresponding P-values. Both left and
right volumes of the nucleus accumbens, hippocampus,
putamen and thalamus are significantly correlating to the
volume of the neocortical grey matter in male and female
subjects. In male subjects the right pallidum also correlates
significantly with the neocortical grey matter volume, and
in female subjects the right amygdala correlates significantly
with neocortical grey matter volume.
Decreased volumes of left putamen and
thalamus correlate independently to poorer
cognitive test results
No multi-collinearity between the selected variables, age,
years of educations, ICV, neocortical grey matter volume,
and volumes of the deep grey matter structures, was found
(all R
2 were found below 0.52). Therefore, all were entered
in the linear regression model which was set up for each
deep grey matter structure separately. b-Regression coeffi-
cients of the correlations between volumes of deep grey
matter structures and the main cognitive tests scores
(the CAMCOG-R, a sub-test on executive function of the
CAMCOG-R and the MMSE) of MCs and subjects with
probable Alzheimer’s disease, are displayed in Table 3. The
corresponding P-values are displayed between brackets.
This table shows that volumes of the left hippocampus, left
putamen and left thalamus in probable Alzheimer’s disease
subjects correlate significantly to all three cognitive test
scores. Also, the right thalamus shows a significant
correlation in probable Alzheimer’s disease subjects with
the MMSE score. The remaining correlations between right
hippocampus, right putamen and right thalamus and
cognitive test scores were stronger compared with the
correlations of the other deep grey matter structures, but
not found significant. In all the regression models between
the hippocampus, putamen and thalamus and the cognitive
test scores of probable Alzheimer’s disease subjects, the
volume of the deep grey matter structure constantly forms
the strongest predictor of cognitive outcome compared to
age, gender, years of education, ICV and neocortical grey
matter volume.
In the linear regression models for MCs the left
hippocampus, both the volume of the left and right
nucleus accumbens, and the right thalamus correlate
significantly to the CAMCOR_R score. The volume of the
left hippocampus also correlates significantly to the MMSE
score. In all regression models of the MCs, however,
the correlation between educational level and cognitive test
Table 2 Mean volumes of deep grey matter structures in cubic centimeter per diagnosis and gender: General Linear Model
applied for estimating group differences (adjusted for age, gender and intra cranial volume)
Memory complainers
Mean volumes (SD) (cm
3)
Probable Alzheimer’s disease
Mean volumes (SD) (cm
3)
B (cm
3)P e a r s o n - c o r r
NeoCor GM
MF M F M F
L AMYG 1.66 (0.28) 1.44 (0.22) 1.62 (0.35) 1.36 (0.27) 0.030 0.13 0.06
R AMYG 1.72 (0.28) 1.47 (0.26) 1.57 (0.32) 1.48 (0.37) 0.054 0.23 0.33

LH I P P 4 . 2 0( 0 . 6 0 ) 3 . 8 3( 0 . 7 4 ) 3 . 7 3( 0 . 6 7 ) 3 . 4 3( 0 . 6 9 ) 0.244
 0.58
 0.33

RH I P P 4 . 2 1( 0 . 7 1 ) 3 . 9 7( 0 . 7 2 ) 3 . 5 7( 0 . 7 8 ) 3 . 3 2( 0 . 6 5 ) 0.295
 0.61
 0.39

LN A C C 0 . 6 4( 0 . 1 6 ) 0 . 5 1( 0 . 1 6 ) 0 . 4 8( 0 . 1 9 ) 0 . 4 2( 0 . 1 4 ) 0.049 0.42
 0.45

R NACC 0.47 (0.17) 0.36 (0.15) 0.35 (0.15) 0.27 (0.10) 0.035 0.32
 0.40

LC N 4 . 4 1( 1 . 0 0 ) 4 . 0 9( 0 . 8 1 ) 4 . 4 9( 0 . 9 0 ) 3 . 7 7( 0 . 8 2 ) 0 . 0 2 7 0 . 1 8 0 . 2 1
RCN 4.96 (0.90) 4.49 (0.60) 5.01 (0.98) 4.09 (0.78) 0.188 0.08 0.02
L PUT 5.90 (0.77) 5.24 (0.61) 5.25 (0.62) 4.53 (0.83) 0.381
 0.53
 0.37

R PUT 6.47 (0.86) 5.56 (0.75) 5.80 (0.81) 5.05 (0.78) 0.285
 0.45
 0.34

L GP 2.36 (0.99) 2.26 (0.73) 2.11 (0.55) 1.97 (0.64) 0.029 0.22 0.12
RG P 2 . 3 9( 0 . 8 8 ) 2 . 1 6( 0 . 7 3 ) 2 . 0 3( 0 . 5 1 ) 1 . 8 3( 0 . 6 7 ) 0.234 0.32
 0.07
LT H 7 . 6 3( 1 . 0 7 ) 7 . 4 0( 1 . 0 3 ) 7 . 2 0( 0 . 8 7 ) 6 . 1 8( 1 . 1 2 ) 0.362
 0.52
 0.51

RT H 7 . 6 8( 0 . 9 5 ) 7 . 2 1( 0 . 9 2 ) 6 . 8 8( 0 . 7 3 ) 6 . 1 7( 1 . 0 8 ) 0.409
 0.61
 0.46

BRAIN 1204 (107) 1085 (123) 1113 (101) 974 (76.9) 41.7
 0.64
 0.63

WHITE 506 (65.7) 458 (57 .5) 522 (93.9) 448 (60.6) 6.40 0.17 0.09
NeoCor GM 511 (78.4) 463 (72.6) 412 (92.8) 395 (87.0) 39.3
 ^^
P40.05,
P40.01.
L: left, R: right; AMYG: amygdala; HIPP: hippocampus; NACC: nucleus accumbens; CN: caudate nucleus; PUT: putamen; GP: globus palli-
dus;TH: thalamus; BRAIN: total of white and grey matter; WHITE: volume of white matter; NeoCor GM: neocortical grey matter minus
volumes of hippocampus and amygdala; M: male; F: female.
Bold figures represent significant B differences between memory complainers and probable Alzheimer’s disease patients after adjustment
f o ra g e ,g e n d e ra n dI C V .
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the deep grey matter and the cognitive test score, with all
P 50.01.
The volumes of the caudate nucleus, amygdala and the
pallidum do not show any significant correlations, with any
of the cognitive test scores, in any of the groups.
Discussion
First of all, in addition to the expected finding of reduced
hippocampal and neocortical grey matter volumes in
Alzheimer’s disease, the current study revealed significantly
reduced volumes of both left and right putamen and
thalamus in patients diagnosed with probable Alzheimer’s
disease relative to MCs. This volume reduction was found
independent of age, gender and ICV. Second, we also
found, that reduced volumes of the putamen and the
thalamus independently correlated with impaired cognitive
functioning in elderly subjects, when controlled for age,
gender, educational level, ICV and neocortical grey matter
volume. To the best of our knowledge, this is the first study
that explicitly associates smaller volumes of putamen and
thalamus with Alzheimer’s disease, and reveals their relation
with cognitive functioning.
The robust finding of smaller volumes of hippocampus,
putamen and thalamus in patients diagnosed with probable
Alzheimer’s disease, strongly suggests that degenerative
pathology affects these structures more or earlier in the
process of Alzheimer’s disease than other deep grey matter
structures. Volumes of brain structures, especially grey
matter volume, have been said to be of protective value
in Alzheimer’s disease (Wolf et al., 2004). Our analysis
supports this idea as well, since the smaller the volumes of
hippocampus, putamen and thalamus, the more impaired
the cognitive results are. In fact, in the Alzheimer’s disease
group, especially the left volumes of the hippocampus,
putamen and thalamus formed the strongest predictors
for cognitive performance. Hippocampal atrophy and its
contribution to memory decline in the process of
Alzheimer’s disease has been described more than once
and is widely accepted (de Leon et al., 1995; Laakso et al.,
1995). On the contrary, putaminal and thalamic volume
reduction in Alzheimer’s disease and their relations to
cognitive decline have not been reported before, and these
findings seem to open a new perspective on Alzheimer’s
disease. The basal nuclei and thalamus are known to
participate in many different neuronal pathways, with
functions that are not just restricted to motor behaviour,
but are also related to emotional, motivational, associative
and cognitive abilities (Herrero et al., 2002). Strength of
our study was the availability of cognitive data for all
subjects. Our data show that volume reduction of the left
putamen and left thalamus are both significantly associated
with global cognitive decline in elderly subjects visiting a
memory clinic and exceed in strength the left hippocampal
correlation to cognitive performance. To interpret this, data
from other studies are needed. The putamen has been
correlated to Alzheimer’s disease, since amyloid deposits are
present early in the disease process (Braak and Braak,
1990). At the moment however, very little is known on the
putaminal role in cognition. Recent literature shows that as
part of the striatum, the putamen is found active in
probabilistic learning tasks (Graybiel, 2005; Bellebaum
et al., 2008) and working memory tasks (Dahlin et al.,
2008). Furthermore the putamen has been correlated with
the emergence of dementia in other neurodegenerative
Table 3 Linear Regression analysis: -coefficients (P-values) of correlations between volumes of deep grey matter regions
and main cognitive test results (adjusted for age, gender, years of education, intra cranial volume and neocortical grey
matter volume)
CAMCOG-R CAMCOG-R exe MMSE
MC pAD MC pAD MC pAD
LA M Y G 0.02 (0.86) 0.13 (0.40) 0.02 (0.89) 0.13 (0.39) 0.07 (0.58) 0.20 (0.16)
RA M Y G 0 . 0 5( 0 . 6 7 ) 0 . 2 0( 0 . 1 7 ) 0.04 (0.73) 0.15 (0.30) 0.09 (0.50) 0.08 (0.59)
LH I P P 0.29 (0.01) 0.28 (0.05) 0.12 (0.33) 0.33 (0.02) 0.30 (0.03) 0.28 (0.05)
R HIPP 0.16 (0.22) 0.18 (0.19) 0.11 (0.42) 0.22 (0.12) 0.29 (0.06) 0.20 (0.15)
LN A C C 0.34 (0.01) 0.04 (0.74) 0.08 (0.58) 0.13 (0.35) 0.23 (0.15) 0.11 (0.41)
RN A C C 0.31 (0.02) 0.17 (0.21) 0.12 (0.37) 0.26 (0.08) 0.19 (0.21) 0.14 (0.31)
LC N 0.04 (0.74) 0.24 (0.10) 0.09 (0.45) 0.26 (0.09) 0.09 (0.50) 0.17 (0.24)
RC N 0.12 (0.30) 0.07 (0.64) 0.07 (0.53) 0.14 (0.39) 0.03 (0.83) 0.14 (0.31)
L PUT 0.19 (0.14) 0.50 (_0.00) 0.06 (0.70) 0.52 (_0.00) 0.18 (0.26) 0.50 (_0.00)
R PUT 0.20 (0.11) 0.25 (0.08) 0.09 (0.48) 0.14 (0.36) 0.17 (0.24) 0.19 (0.21)
LG P 0 . 07(0 .5 2 ) 0.09 (0.48) 0.1 1 (0.30) 0.16 (0.22) 0.08 (0.52) 0.13 (0.33)
RG P 0 . 0 2(0 . 89) 0.08 (0.53) 0.03 (0.82) 0.02 (0.90) 0.08 (0.52) 0.09 (0.47)
LTH 0 . 07(0 . 60) 0.37 (0.01) 0.00 (0.96) 0.43 (_0.00) 0.16 (0.33) 0.37 (0.02)
RT H 0.39 (0.01) 0.21 (0.17) 0.08 (0.64) 0.18 (0.27) 0.27 (0.15) 0.31 (0.04)
CAMCOG-R exe=CAMbridge COGnition examination Revised executive functioning; L=left; R=right; AMYG=amygdala;
HIPP=hippocampus; NACC=nucleus accumbens; CN=caudate nucleus; PUT=putamen; GP=globus pallidus; TH=thalamus.
Bold figures represent significant correlation-coefficients after adjustment for age, gender, years of education, ICVand neocortical
grey matter.
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other neurochemical deficits (Emre, 2003), indicating once
more that its effect on cognitive impairment might be
greater than previously assumed. Whether the putamen in
the process of Alzheimer’s disease influences cognition due
to impaired putaminal primary cognitive functions, inade-
quate neurochemical functioning, or discontinuing the
cortico-thalamic projections, could not be answered in
this study, and is an interesting topic for further research.
In contrast to the putamen, slightly more is known on the
thalamus and its relation to cognition. The thalamus
consists of multiple nuclei and is classically metaphorized
as an active relay centre. The thalamus serves both sensory
and motor mechanisms (Herrero et al., 2002). Cognitively
it is involved in directing attention and suppressing
irrelevant sensory input (Newman, 1995) and its anterior,
medial-dorsal, intralaminar and midline nuclei are impor-
tant for memory functions (Van der Werf et al., 2000).
Thalamic atrophy has been related to cognitive performance
in other neurodegenerative disorders, like Huntington’s
disease (Kassube et al., 2005) and multiple sclerosis
(Houtchens et al., 2007), and herein affected mostly the
executive functioning of patients. As part of the limbic
system, atrophy of the anterior part of the thalamus in
Alzheimer’s disease has been described. Callen et al.
reported that the anterior part of the thalamus was
significantly smaller in Alzheimer’s disease patients than
in healthy controls (Callen et al., 2001). However, the size
reduction of the thalamus in our study cannot entirely be
explained by reduction of the anterior nuclei alone and
suggests that other nuclei of the thalamus are also prone to
atrophy in Alzheimer’s disease, in which the large medial-
dorsal nucleus is an important candidate. Supportive to this
thought was the finding of Braak et al. in 1991, that in all
limbic nuclei of the thalamus extracellular amyloid deposits
and neurofibrillary tangles occur, although the most severe
involvement was found in the medial-dorsal nucleus (Braak
and Braak, 1991). In summary, our study adds to the
present knowledge, that is the presence of neurofibrillary
tangles and amyloid plaques in the striatum and thalamus
early in the disease process of Alzheimer’s disease, the
finding of a clear reduction in size of the putamen and the
thalamus compared to controls without memory deficits.
Moreover the reduction in size of the putamen and
thalamus, especially the left side, was correlated to global
cognitive decline. At the present no clear explanation can
be given on difference in correlational strength between left
and right side of the putamen and thalamus. Part might be
due to the dominant presence of the right-handedness
among subjects in this population. Another explanation
might be that the tested cognitive functions are more
prominent on the left side. Whether shrinkage of the
putamen and thalamus is a primary or a secondary
phenomenon in the pathology of Alzheimer’s disease, also
remains speculative.
The presented data suggest that in Alzheimer’s disease
some structures are affected by atrophy (i.e. the neocortical
grey matter and hippocampus, putamen and thalamus)
whereas others are relatively preserved (i.e. the amygdala,
nucleus accumbens, caudate nucleus, pallidum and white
matter). In previous studies it has been shown, however,
that atrophy of the amygdala and caudate nucleus are also
associated with Alzheimer’s disease; our data do not
confirm this, though. The volumetric data show that the
amygdala is smaller in the probable Alzheimer’s disease
group compared to the MCs, but this reduction in size was
not significant when controlled for age, gender and ICV.
We applied a rather strict analysis to assess significance
between MCs and probable Alzheimer’s disease subjects,
therefore possible shrinkage of the amygdala could have lost
its significance. Another explanation might be that amygdala
is affected later in the disease process of Alzheimer’s disease
than the hippocampus, the putamen and thalamus, and
therefore not prominent in MR imaging of patients that
attended the memory clinic for the first time. The caudate
nucleus was also not significantly smaller in MCs than in
probable Alzheimer’s disease patients, as were the nucleus
accumbens, pallidum and white matter volumes. None of
these volumes showed a significant correlation with any of
the cognitive test scores except for the nucleus accumbens
which was significantly correlated to the CAMCOG-R score
in MCs, but not in probable Alzheimer’s disease subjects.
Our study did not show a significant reduction in size of
the nucleus accumbens in probable Alzheimer’s disease
subjects compared to MCs, but found it strongly correlated
to the neocortical grey matter volume. A possible explana-
tion for this relation to neocortical grey matter volume and
cognitive decline in MCs, is that the nucleus accumbens is
affected in old age, but not specifically in Alzheimer’s
disease. Another explanation is that the structure is just too
small, relative to the other deep grey matter structures, to
obtain sensitive data with our method.
One limitation of our study was that the MCs could not
be regarded as a healthy control group. Several studies have
already revealed the presence of smaller left hippocampal
volumes and decreased grey matter volumes among MCs,
suggesting that this condition for some subjects forms a
pre-cursor condition to Alzheimer’s disease (van der Flier
et al., 2004; Saykin et al., 2006). However the MCs form
a relevant control group, since if Alzheimer’s disease
pathology is present; it is in a very early stage and very
likely to be less pronounced than in clinical stages of
Alzheimer’s disease.
Another limitation of our study could be the relative
novelty of the software adopted from FSL. However,
we could not detect any significant mismatches in
segmentation of the subcortical structures performed by
the algorithm (Figs 1 and 2 are a 2D-represenations of
segmented subcortical structures by FIRST). Furthermore,
the method of semi-automatic volumetry has clear
advantages compared to voxel based morphometry and
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shown its value in comparing groups of subjects in patterns
of atrophy, but is prone to registration artifacts in the deep
grey matter and not suitable for analysis of the pattern of
atrophy in an individual subject (Bookstein, 2001; Frisoni
and Whitwell, 2008). The method of semi-automatic
volumetry can be used to measure volumes of different
regions in individual subjects and gives an indication of the
actual amount of atrophy that occurs. Therefore, it is more
patient specific and can be used as marker for disease
progression on an individual level. Compared to manual
segmentation, the method used has the advantage that
its segmentation is based on voxel intensities, while in
manual segmentation the contrast differences can be
difficult to detect visually. Furthermore, since the method
used is automatic researcher bias in segmentation is absent.
A third limitation of our study is that because of the
cross-sectional nature of the study the question whether
shrinkage of the thalamus, nucleus accumbens and putamen
is a primary or secondary phenomenon to hippocampal or
neo cortical loss, could not be answered.
In conclusion, the present study demonstrates that
besides global atrophy of the neocortex and atrophy
of the medial temporal lobe, parts of the basal nuclei and
thalamus are also affected in Alzheimer’s disease.
Furthermore, our study suggests that putaminal and
thalamic atrophy play pivotal roles in cognitive decline in
patients with Alzheimer’s disease.
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